EUVIMEDEUVIMED entdecken
Open Access

Targeting granulosa cells with engineered DFO nanoparticles for the treatment of chemotherapy-induced premature ovarian failure

Tuo Zhang, Zhiyi Sheng, Jixian Zhang, Heng Zhang, Yan Zhang, Yunpeng Du, Xiangxin Liu, Zhu Hu, Qiyuan Luo, Guoqiang Xu, Yuan Gao, Meina He und 1 weitere

Theranostics · 04.07.2025 · 15 (15) · 7820-7840

DOI: 10.7150/thno.115416 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 04.07.2025. Verfasst von Tuo Zhang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Transformation Engineering Research Center of Chronic Disease Diagnosis and Treatment, Department of Physiology, College of Basic Medicine, Guizhou M…. Hauptthemen laut MEDLINE: Primary Ovarian Insufficiency, Granulosa Cells, Nanoparticles, Deferoxamine. Die Arbeit wurde bisher 15-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary Ovarian InsufficiencyGranulosa CellsNanoparticlesDeferoxamineAntineoplastic AgentsFemaleAnimalsMiceReactive Oxygen SpeciesFerroptosisHumansIronMitochondriaPolymersDisease Models, AnimalIndolesReceptors, Transferrin

Stichwörter der Autor:innen

engineered DFO nanoparticlesferritinophagyferroptosispremature ovarian failurethe labile iron pool

Substanzen

Reactive Oxygen SpeciesDeferoxamineAntineoplastic AgentsIronpolydopaminePolymersIndolesReceptors, Transferrin

Autor:innen und Institutionen

  • Transformation Engineering Research Center of Chronic Disease Diagnosis and Treatment, Department of Physiology, College of Basic Medicine, Guizhou Medical University, Guiyang, Guizhou, 561113, China.
  • Guizhou Provincial Key Laboratory of Pathogenesis & Drug Research on Common Chronic Diseases, Guizhou Medical University, Guiyang, Guizhou, 561113, China.
  • Center for Reproductive Medicine, Shandong University, Jinan, 250012, China.

Zitieren

APA

Zhang, T., Sheng, Z., Zhang, J., Zhang, H., Zhang, Y., Du, Y., Liu, X., Hu, Z., Luo, Q., Xu, G., Gao, Y., He, M., & Chen, T. (2025). Targeting granulosa cells with engineered DFO nanoparticles for the treatment of chemotherapy-induced premature ovarian failure. Theranostics, 15(15), 7820-7840. https://doi.org/10.7150/thno.115416

Vancouver

Zhang T, Sheng Z, Zhang J, Zhang H, Zhang Y, Du Y, et al. Targeting granulosa cells with engineered DFO nanoparticles for the treatment of chemotherapy-induced premature ovarian failure. Theranostics. 2025;15(15):7820-7840. doi:10.7150/thno.115416

BibTeX
@article{Zhang2025,
  author = {Zhang, Tuo and Sheng, Zhiyi and Zhang, Jixian and Zhang, Heng and Zhang, Yan and Du, Yunpeng and Liu, Xiangxin and Hu, Zhu and Luo, Qiyuan and Xu, Guoqiang and Gao, Yuan and He, Meina and Chen, Tengxiang},
  title = {Targeting granulosa cells with engineered DFO nanoparticles for the treatment of chemotherapy-induced premature ovarian failure},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {15},
  pages = {7820--7840},
  doi = {10.7150/thno.115416}
}
Kostenlos starten →